Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

VitaNova Life Sciences (YJGJ) Debt Ratio (2017 - 2025)

VitaNova Life Sciences (YJGJ) has disclosed Debt Ratio for 7 consecutive years, with 0.08 as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Debt Ratio rose 71.66% year-over-year to 0.08, compared with a TTM value of 0.08 through Jan 2025, up 71.66%, and an annual FY2024 reading of 0.0, down 99.86% over the prior year.
  • Debt Ratio was 0.08 for Q1 2025 at VitaNova Life Sciences, down from 0.1 in the prior quarter.
  • Across five years, Debt Ratio topped out at 1.84 in Q2 2023 and bottomed at 0.0 in Q2 2024.
  • Average Debt Ratio over 5 years is 0.46, with a median of 0.31 recorded in 2022.
  • The sharpest move saw Debt Ratio skyrocketed 411.18% in 2023, then plummeted 99.86% in 2024.
  • Year by year, Debt Ratio stood at 0.38 in 2021, then decreased by 9.94% to 0.34 in 2022, then surged by 436.47% to 1.84 in 2023, then crashed by 94.49% to 0.1 in 2024, then dropped by 24.07% to 0.08 in 2025.
  • Business Quant data shows Debt Ratio for YJGJ at 0.08 in Q1 2025, 0.1 in Q4 2024, and 0.05 in Q3 2024.